or
forgot password

Dynasplint Therapy for Trismus in Head and Neck Cancer


N/A
20 Years
N/A
Open (Enrolling)
Both
Trismus

Thank you

Trial Information

Dynasplint Therapy for Trismus in Head and Neck Cancer


Inclusion Criteria:



- Patients with a 30 mm mouth opening or 40 mm mouth opening if edentulous

- Prior treatment for head and neck cancer.

Exclusion Criteria:

- Severe periodontal or gum disease that has caused teeth to be loose

- Any systemic disease that causes blistering of the oral mucosa.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Assess effectiveness of DTS on improved ability to open the mouth

Outcome Time Frame:

12 months

Safety Issue:

No

Principal Investigator

William Carroll, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Alabama at Birmingham

Authority:

United States: Institutional Review Board

Study ID:

F07032314

NCT ID:

NCT00507208

Start Date:

July 2007

Completion Date:

December 2016

Related Keywords:

  • Trismus
  • Trismus
  • Patients who experience Trismus after completion of treatment for head and neck cancer
  • Head and Neck Neoplasms
  • Trismus

Name

Location
UAB Division of Otolaryngology Birmingham, Alabama  35233